May 2019, Munich, Germany -12th BioVaria annual Tech-Transfer conference welcomed over 250 life-science innovators to Munich, including biopharma executives, investors, academic inventors, entrepreneurs and technology transfer experts. Once again BioVaria brought academia and industry together, when over 60 licensing opportunities and 17 start-ups were offered, originating from different research institutes, universities, university hospitals from all over the Europe. Participants actively engaged in technology discussions, competitions and panels, and numerous one-on-ones were held to initiate collaborations.
Czech project Mindpax.me that develops a digital solution for monitoring individual biorhythms to help prevent mental health attacks, won a prestigious ‘Rising’ category of the BioVaria ‘Start-up Pitch & Partner Competition‘. Mindpax.me holds strong potential to improve quality of life for millions of patients, while considerably reducing healthcare costs. The ‘Emerging’ category of the competition was won by a Danish Aarthus University spin-out ISD Immunotech for their novel approach for the treatment of severe SLE (systemic lupus erythematosus).
Pavel Nevický, co-founder of Mindpax.me stated: ‘We are honoured to be chosen best Rising Startup at BioVaria, and the award strengthens our determination to apply digital diagnostic tools to the treatment of severe mental health disorders.’
The i&i Prague team is proud to identify the most promising Czech BioTech projects and help them find partnership and investments on a global scale.
More information about the competition and some of the technologies and start-ups presented during BioVaria 2019 are now available at www.biovaria.org